These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
280 related items for PubMed ID: 29751820
1. Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer. Tian X, Guan W, Zhang L, Sun W, Zhou D, Lin Q, Ren W, Nadeem L, Xu G. J Exp Clin Cancer Res; 2018 May 11; 37(1):103. PubMed ID: 29751820 [Abstract] [Full Text] [Related]
2. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer. Zhang L, Zhou D, Guan W, Ren W, Sun W, Shi J, Lin Q, Zhang J, Qiao T, Ye Y, Wu Y, Zhang Y, Zuo X, Connor KL, Xu G. Cell Death Dis; 2017 Dec 13; 8(12):3214. PubMed ID: 29238081 [Abstract] [Full Text] [Related]
5. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/β-Catenin Signaling. Xie M, Fu Q, Wang PP, Cui YL. Dis Markers; 2021 Dec 13; 2021():1405045. PubMed ID: 34790276 [Abstract] [Full Text] [Related]
10. The Role of PAR2 in TGF-β1-Induced ERK Activation and Cell Motility. Ungefroren H, Witte D, Fiedler C, Gädeken T, Kaufmann R, Lehnert H, Gieseler F, Rauch BH. Int J Mol Sci; 2017 Dec 20; 18(12):. PubMed ID: 29261154 [Abstract] [Full Text] [Related]
11. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5. Zeeh F, Witte D, Gädeken T, Rauch BH, Grage-Griebenow E, Leinung N, Fromm SJ, Stölting S, Mihara K, Kaufmann R, Settmacher U, Lehnert H, Hollenberg MD, Ungefroren H. Oncotarget; 2016 Jul 05; 7(27):41095-41109. PubMed ID: 27248167 [Abstract] [Full Text] [Related]
12. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E, Buganim Y, Shapira KE, Besserglick H, Goldfinger N, Weisz L, Stambolsky P, Henis YI, Rotter V. Mol Cell Biol; 2007 Dec 05; 27(23):8228-42. PubMed ID: 17875924 [Abstract] [Full Text] [Related]
16. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. EMBO J; 2002 Apr 02; 21(7):1743-53. PubMed ID: 11927558 [Abstract] [Full Text] [Related]
18. Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer. Basal E, Ayeni T, Zhang Q, Langstraat C, Donahoe PK, Pepin D, Yin X, Leof E, Cliby W. Curr Mol Med; 2016 Apr 02; 16(3):222-31. PubMed ID: 26917267 [Abstract] [Full Text] [Related]
19. Dual roles of TGF-β signaling in the regulation of dental epithelial cell proliferation. Zhang H, Zhan Y, Zhang Y, Yuan G, Yang G. J Mol Histol; 2021 Feb 02; 52(1):77-86. PubMed ID: 33206256 [Abstract] [Full Text] [Related]